cover
Article Menu

Journal Browser
Vol. 5 (2026)
Vol. 4 (2025)
Vol. 3 (2024)
Vol. 2 (2023)
Vol. 1 (2022)
Journal Insights

Frequency: Quarterly

Time to first decision: 2.1 Weeks

Submission to publication: 4 Weeks

Acceptance rate: 31 %

E-ISSN: 2972-3272

Announcement More >>
Blog More >>
1 January 2024
EAL's New Year Blessing
Recommend Papers
Psychopathy, prospect theory, and the Madoff Curve: a dual behavioral neuroscience and behavioral economic framework for understanding White Collar Crime
Psychopathy, prospect theory, and the Madoff Curve: a dual behavioral neuroscience and behavioral economic framework for understanding White Collar Crime
Regime Change Operation in Pakistan: Examining Yield as a Behavioral Pattern of Microblogging rumors during the Political-Obsessed Period
Regime Change Operation in Pakistan: Examining Yield as a Behavioral Pattern of Microblogging rumors during the Political-Obsessed Period
COVID-19 and non-communicable diseases: GMM/IV Panel VAR evidence from US states
COVID-19 and non-communicable diseases: GMM/IV Panel VAR evidence from US states
Microblogging Perceptive and Pricing Liquidity: Exploring Asymmetric Information as a Risk Determinant of Liquidity in the Pandemic Environments
Microblogging Perceptive and Pricing Liquidity: Exploring Asymmetric Information as a Risk Determinant of Liquidity in the Pandemic Environments
Digital Technologies Asset’s value Synthetic Control GDP per capita Singapore Strategic Economic Plan Yields Liquidity Risk Trading Economic Sanctions Multimarket contact Financing constraint Market position Trade credit financing Corporate financialization Market Timing Japanese Stock Markets Performance ETFs Synthetic Difference-in-Differences

Crossref Metrics

Data source: Crossref
Open Access Review

Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care

by Ioanna Tsatsou a,*
a
One Day Clinic, Oncology-Hematology Department, Hellenic Airforce General Hospital, Athens, Greece
*
Author to whom correspondence should be addressed.
EAL  2025 4(3):84; https://doi.org/10.58567/eal04030001
Received: 11 May 2025 / Accepted: 19 July 2025 / Published Online: 6 August 2025
View Full-Text
Download PDF

Abstract

The global cancer burden continues to rise, placing immense strain on healthcare systems and economies. Concurrently, advancements in new technologies and artificial intelligence (AI) are revolutionizing cancer care, from diagnosis to treatment. While these innovations promise improved outcomes and efficiency, they also introduce complex economic implications. This manuscript explores the economic costs and benefits of integrating new technologies and AI into cancer care. The associated costs, including accessibility, availability, and sustainability challenges are defined and analyzed. Furthermore, the economic benefits these technologies bring to healthcare systems, patients, and professionals are evaluated. There are many ways to harness the potential of technological innovations while ensuring equitable, cost-effective cancer care.

Keywords: Cancer Care; Artificial Intelligence; New Technologies; Healthcare Innovation; Sustainable Healthcare;
Copyright: © 2025 by Tsatsou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Cite This Paper
APA Style
Tsatsou, I. (2025). Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care. Economic Analysis Letters, 4(3), 84. doi:10.58567/eal04030001
ACS Style
Tsatsou, I. Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care. Economic Analysis Letters, 2025, 4, 84. doi:10.58567/eal04030001
AMA Style
Tsatsou I.. Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care. Economic Analysis Letters; 2025, 4(3):84. doi:10.58567/eal04030001
Chicago/Turabian Style
Tsatsou, Ioanna 2025. "Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care" Economic Analysis Letters 4, no.3:84. doi:10.58567/eal04030001

Share and Cite

ACS Style
Tsatsou, I. Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care. Economic Analysis Letters, 2025, 4, 84. doi:10.58567/eal04030001
AMA Style
Tsatsou I.. Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care. Economic Analysis Letters; 2025, 4(3):84. doi:10.58567/eal04030001
Chicago/Turabian Style
Tsatsou, Ioanna 2025. "Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care" Economic Analysis Letters 4, no.3:84. doi:10.58567/eal04030001
APA style
Tsatsou, I. (2025). Economic Implications of Emerging Technologies and Artificial Intelligence in Global Cancer Care. Economic Analysis Letters, 4(3), 84. doi:10.58567/eal04030001

Article Metrics

Article Access Statistics

References

  1. Abdul Rasool Hassan, B., Mohammed, A. H., Hallit, S., Malaeb, D., and Hosseini, H. (2025). Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook. Frontiers in oncology, 15, 1475893. https://doi.org/10.3389/fonc.2025.1475893
  2. Abdul, S., Adeghe, E. P., Adegoke, B. O., Adegoke, A. A., and Udedeh, E. H. (2024). Public-private partnerships in health sector innovation: Lessons from around the world. Magna Scientia Advanced Biology and Pharmacy, 12(1), 045-059. https://doi.org/10.30574/msabp.2024.12.1.0032
  3. Amann, J., Blasimme, A., Vayena, E., Frey, D., and Madai, V. I. (2020). Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Medical Informatics and Decision Making, 20(1), 310. https://doi.org/10.1186/s12911-020-01332-6
  4. Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., ... and Albekairy, A. M. (2023). Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC medical education, 23(1), 689. https://doi.org/10.1186/s12909-023-04698-z
  5. Ayoola, A. A., Adeoye, O. F., Ayoola, A., and Joy, A. (2024). Leveraging artificial intelligence to alleviate nurse workload and improve patient care. ResearchGate Health Operations, 11(2), 45-59. https://doi.org/10.54660/IJPGRR.2025.2.1.17-27
  6. Bachina, L., and Kanagala, A. (2023). Health revolution: AI-powered patient engagement. International Journal of Chemical and Biochemical Sciences, 24(5), 2023.
  7. Bhinder, B., Gilvary, C., Madhukar, N. S., and Elemento, O. (2021). Artificial Intelligence in Cancer Research and Precision Medicine. Cancer discovery, 11(4), 900–915. https://doi.org/10.1158/2159-8290.CD-21-0090
  8. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., and Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
  9. Chang, K., Gidwani, M., Patel, J. B., Li, M. D., and Kalpathy-Cramer, J. (2021). Data Curation Challenges for Artificial Intelligence. In Auto-Segmentation for Radiation Oncology, 201-216. CRC Press. https://doi.org/10.1201/9780429323782-17
  10. Charow, R., Jeyakumar, T., Younus, S., Dolatabadi, E., Salhia, M., Al-Mouaswas, D., ... and Wiljer, D. (2021). Artificial intelligence education programs for health care professionals: scoping review. JMIR Medical Education, 7(4), e31043. https://doi.org/10.2196/31043
  11. Chen, Y. H., Blommestein, H. M., Klazenga, R., Uyl-de Groot, C., and van Vulpen, M. (2023). Costs of newly funded proton therapy using time-driven activity-based costing in the Netherlands. Cancers, 15(2), 516. https://doi.org/10.3390/cancers15020516
  12. Drake, T. M., Knight, S. R., Harrison, E. M., and Søreide, K. (2018). Global inequities in precision medicine and molecular cancer research. Frontiers in Oncology, 8, 346. https://doi.org/10.3389/fonc.2018.00346
  13. Dubey, A., and Verma, A. S. (2022). Effective remote healthcare and telemedicine approaches for improving digital healthcare systems. In Digital Health Transformation with Blockchain and Artificial Intelligence, 273-297. CRC Press. https://doi.org/10.1201/9781003247128-15
  14. Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., ... and Wang, Y. (2017). Artificial intelligence in healthcare: past, present and future. Stroke and vascular neurology, 2(4). https://doi.org/10.1136/svn-2017-000101
  15. Esmaeilzadeh, P. (2024). Challenges and strategies for wide-scale artificial intelligence (AI) deployment in healthcare practices: A perspective for healthcare organizations. Artificial Intelligence in Medicine, 151, 102861. https://doi.org/10.1016/j.artmed.2024.102861
  16. Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., ... and Dean, J. (2019). A guide to deep learning in healthcare. Nature Medicine, 25(1), 24–29. https://doi.org/10.1038/s41591-018-0316-z
  17. Filip, R., Gheorghita Puscaselu, R., Anchidin-Norocel, L., Dimian, M., and Savage, W. K. (2022). Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems. Journal of personalized medicine, 12(8), 1295. https://doi.org/10.3390/jpm12081295
  18. Greenhalgh, T., Wherton, J., Papoutsi, C., Lynch, J., Hughes, G., Hinder, S., ... and Shaw, S. (2017). Beyond adoption: a new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies. Journal of medical Internet research, 19(11), e8775. https://doi.org/10.2196/jmir.8775
  19. Haefner, N., Parida, V., Gassmann, O., and Wincent, J. (2023). Implementing and scaling artificial intelligence: A review, framework, and research agenda. Technological Forecasting and Social Change, 197, 122878. https://doi.org/10.1016/j.techfore.2023.122878
  20. Haffner, M. C., Zwart, W., Roudier, M. P., True, L. D., and Nelson, W. G. (2021). Genomic and phenotypic heterogeneity in prostate cancer. Nature Reviews Urology, 18(2), 79–92. https://doi.org/10.1038/s41585-020-00400-w
  21. Hassan, E., and Omenogor, C. E. (2025). AI powered predictive healthcare: Deep learning for early diagnosis, personalized treatment, and disease prevention. International Journal of Science and Research Archive, 2025, 14(03), 806-823. https://doi.org/10.30574/ijsra.2025.14.3.0731
  22. He, J., Baxter, S. L., Xu, J., Xu, J., Zhou, X., and Zhang, K. (2019). The practical implementation of artificial intelligence technologies in medicine. Nature Medicine, 25(1), 30–36. https://doi.org/10.1038/s41591-018-0307-0
  23. Hollingsworth, B. (2008). The measurement of efficiency and productivity of health care delivery. Health economics, 17(10), 1107-1128. https://doi.org/10.1002/hec.1391
  24. Horgan, D., Mia, R., Erhabor, T., Hamdi, Y., Dandara, C., Lal, J. A., ... and Barrera-Saldana, H. A. (2022). Fighting cancer around the world: A framework for action. In Healthcare, 10(11), 2125. MDPI. https://doi.org/10.3390/healthcare10112125
  25. Kerr, D. J., Jani, A., and Gray, S. M. (2016). Strategies for sustainable cancer care. American Society of Clinical Oncology Educational Book, 36, e11-e15. https://doi.org/10.1200/EDBK_156142
  26. Khozin, S., Blumenthal, G. M., and Pazdur, R. (2017). Real-world data for clinical evidence generation in oncology. J Natl Cancer Inst, 109(11), djx187. https://doi.org/10.1093/jnci/djx187
  27. London, A. J. (2019). Artificial intelligence and black-box medical decisions: accuracy versus explainability. Hastings Center Report, 49(1), 15–21. https://doi.org/10.1002/hast.973
  28. Luengo-Fernandez, R., Leal, J., Gray, A., and Sullivan, R. (2013). Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncology, 14(12), 1165–1174. https://doi.org/10.1016/S1470-2045(13)70442-X
  29. Martínez-Peláez, R., Ochoa-Brust, A., Rivera, S., Félix, V. G., Ostos, R., Brito, H., ... and Mena, L. J. (2023). Role of digital transformation for achieving sustainability: mediated role of stakeholders, key capabilities, and technology. Sustainability, 15(14), 11221. https://doi.org/10.3390/su151411221
  30. Mennella, C., Maniscalco, U., De Pietro, G., and Esposito, M. (2024). Ethical and regulatory challenges of AI technologies in healthcare: A narrative review. Heliyon, 10(4), e26297. https://doi.org/10.1016/j.heliyon.2024.e26297
  31. Ngiam, K. Y., and Khor, I. W. (2019). Big data and machine learning algorithms for health-care delivery. Lancet Oncology, 20(5), e262–e273. https://doi.org/10.1016/S1470-2045(19)30149-4
  32. Obermeyer, Z., and Emanuel, E. J. (2016). Predicting the future — big data, machine learning, and clinical medicine. New England Journal of Medicine, 375(13), 1216–1219. https://doi.org/10.1056/NEJMp1606181
  33. Obermeyer, Z., Powers, B., Vogeli, C., and Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447–453. https://doi.org/10.1126/science.aax2342
  34. Parikh, R. B., Obermeyer, Z., and Navathe, A. S. (2019). Regulation of predictive analytics in medicine. Science, 363(6429), 810–812. https://doi.org/10.1126/science.aaw0029
  35. Patel, M. I., Lopez, A. M., Blackstock, W., Reeder-Hayes, K., Moushey, E. A., Phillips, J., and Tap, W. (2020). Cancer disparities and health equity: a policy statement from the American Society of Clinical Oncology. Journal of Clinical Oncology, 38(29), 3439-3448. https://doi.org/10.1200/JCO.20.00642
  36. Prager, G. W., Braga, S., Bystricky, B., Qvortrup, C., Criscitiello, C., Esin, E., ... and Ilbawi, A. (2018). Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO open, 3(2), e000285. https://doi.org/10.1136/esmoopen-2017-000285
  37. Pramesh, C. S., Badwe, R. A., and Sinha, R. K. (2014). The national cancer grid of India. Indian Journal of Medical and Paediatric Oncology, 35(3), 226. https://doi.org/10.4103/0971-5851.142040
  38. Ramezani, M., Takian, A., Bakhtiari, A., Rabiee, H. R., Ghazanfari, S., and Sazgarnejad, S. (2023). Research agenda for using artificial intelligence in health governance: interpretive scoping review and framework. BioData mining, 16(1), 31. https://doi.org/10.1186/s13040-023-00346-w
  39. Rajkomar, A., Dean, J., and Kohane, I. (2019). Machine learning in medicine. New England Journal of Medicine, 380(14), 1347–1358. https://doi.org/10.1056/NEJMra1814259
  40. Siegel, R. L., Giaquinto, A. N., and Jemal, A. (2024). Cancer statistics, 2024. CA: a cancer journal for clinicians, 74(1), 12-49. https://doi.org/10.3322/caac.21820
  41. Thomas, R., Chalkidou, K. (2016). Cost–effectiveness analysis. In: Cylus J, Papanicolas I, Smith PC, editors. Health system efficiency: How to make measurement matter for policy and management [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies. (Health Policy Series, 46.) 6. Available from: https://www.ncbi.nlm.nih.gov/books/NBK436886/
  42. Topol, E. (2019). Deep medicine: how artificial intelligence can make healthcare human again. Basic Books. Hachette UK.
  43. Valieva, E. N., Yarullin, R. R., Zhelonkin, N. N., and Mayorskaya, A. S. (2021). Innovations in financial sustainability management of public health care organizations. In Engineering Economics: Decisions and Solutions from Eurasian Perspective, 191-200. Springer International Publishing. https://doi.org/10.1007/978-3-030-53277-2_22
  44. Vanshi, H. S., Khalid, M., Singh, S. P., Gupta, M., and Kumar, A. (2024). A review: Innovative technologies in cancer care. World Journal of Advanced Research and Reviews, 2024, 24(03), 2581-2589. https://doi.org/10.30574/wjarr.2024.24.3.3974
  45. Vellekoop, H., Versteegh, M., Huygens, S., Ramos, I. C., Szilberhorn, L., Zelei, T., ... and Rutten-van Mölken, M. (2022). The net benefit of personalized medicine: a systematic literature review and regression analysis. Value in Health, 25(8), 1428-1438. https://doi.org/10.1016/j.jval.2022.01.006
  46. World Health Organization. (2024). Global cancer burden growing, amidst mounting need for services. Retrieved from https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services
  47. Yabroff, K. R., Lund, J., Kepka, D., and Mariotto, A. (2011). Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiology, Biomarkers & Prevention, 20(10), 2006–2014. https://doi.org/10.1158/1055-9965.EPI-11-0650
  48. Yu, K. H., Beam, A. L., and Kohane, I. S. (2018). Artificial intelligence in healthcare. Nature Biomedical Engineering, 2(10), 719–731. https://doi.org/10.1038/s41551-018-0305-z
  49. Zurynski, Y., Herkes-Deane, J., Holt, J., McPherson, E., Lamprell, G., Dammery, G., Meulenbroeks, I., Halim, N., and Braithwaite, J. (2022). How can the healthcare system deliver sustainable performance? A scoping review. BMJ open, 12(5), e059207. https://doi.org/10.1136/bmjopen-2021-059207